Related by context. All words. (Click for frequent words.) 75 TEAEs 74 hypoglycemic episodes 73 hypoglycaemic episodes 72 extrapyramidal symptoms 71 severe hypoglycemia 70 cerebrovascular events 69 glycated hemoglobin levels 69 insulin detemir 69 severe hypoglycemic 69 hypoglycaemia 69 macrovascular events 69 severe hypoglycaemia 68 severe exacerbations 68 thromboembolic events 68 nocturnal hypoglycaemia 68 hematologic toxicity 68 ALT flares 68 incontinence episodes 68 hemorrhagic complications 67 hyperkalemia 67 intracranial hemorrhage ICH 67 clinically meaningful reductions 67 arterial thromboembolic events 67 elevated ALT 67 hypoglycemia 67 transaminase elevations 67 gout flares 67 QTc prolongation 67 APTIVUS r 67 NPH insulin 67 ocular adverse 67 leucopenia 66 bolus dose 66 Torsades de Pointes 66 baseline HbA1c 66 HbA1C levels 66 nocturnal hypoglycemia 66 reinfarction 66 aminotransferases 66 recurrent venous thromboembolism 66 lopinavir r arm 66 nonvertebral fracture 66 prolonged QT interval 66 myopathy rhabdomyolysis 66 oral antidiabetes 66 Febrile neutropenia 66 lipid parameters 66 nicardipine 66 virologic breakthrough 66 cytopenias 66 Erythropoietic therapies may 66 laboratory abnormalities 66 Hypotension 66 HbA 1c 66 postoperative AF 66 nonfatal MI 66 apnea hypopnea 65 serum potassium 65 QT interval prolongation 65 salmeterol HFA MDI 65 HbA1c levels 65 RLS symptoms 65 serum urate 65 periprocedural 65 oxycodone CR 65 comorbid conditions 65 hematological adverse 65 treatment emergent adverse 65 CIMZIA ™ 65 intravenous bisphosphonates 65 TMP SMX 65 HbA 1c levels 65 nighttime awakenings 65 left ventricular dysfunction 65 TNF antagonist 65 thrombotic events 65 generalized edema 65 severe hypersensitivity reactions 65 intracerebral haemorrhage 65 PASI scores 65 hemoglobin A1c levels 64 QTc intervals 64 intravitreal injections 64 neurologic complications 64 urate lowering therapy 64 EXJADE 64 β blocker 64 alpha interferons 64 morphometric vertebral fractures 64 oral antidiabetic drugs 64 hematologic adverse 64 thromboembolism 64 β blockers 64 thromboembolic 64 hemoglobin A1c HbA1c 64 oral olanzapine 64 Toxicities 64 hyperprolactinemia 64 nondiabetic patients 64 + PH# 64 hypercholesterolaemia 64 recurrent ischemia 64 recurrent VTE 64 symptom exacerbation 64 peripheral sensory neuropathy 64 Infusion Reactions Severe 64 aldosterone antagonist 64 definite stent thrombosis 64 syncopal 64 atherogenic dyslipidemia 64 severe neutropenia 64 oxygen desaturation 64 octreotide LAR 64 postoperative infections 64 HPA axis suppression 64 neutropaenia 64 antihypertensive medications 64 ATACAND 63 treatment emergent AEs 63 corticosteroid therapy 63 1mg dose 63 prednisone prednisolone 63 oral diclofenac 63 fatal anaphylactic 63 postoperative mortality 63 OADs 63 apnea hypopnea index 63 Hypoglycemia 63 macroalbuminuria 63 proliferative diabetic retinopathy 63 somnolence dizziness 63 torsades de pointes 63 MACCE 63 dopaminergic therapy 63 Postoperative complications 63 adrenal insufficiency 63 bone marrow suppression 63 microvascular complications 63 sotalol 63 COPD exacerbation 63 isoproterenol 63 postoperative morbidity 63 fasting plasma glucose 63 Stent thrombosis 63 lispro 63 postoperative complication 63 acarbose 63 lipid lowering agents 63 NovoLog ® Mix 63 frequent awakenings 63 mcg QD 63 reflux symptoms 63 nephrotoxicity 63 tapentadol ER 63 haematologic 63 daytime drowsiness 63 akathisia 63 Adverse events 63 vasomotor symptoms 63 Hypersensitivity reactions 63 pyridostigmine 63 glycosylated hemoglobin HbA1c 63 MMSE score 63 hypoxemia 63 analgesic medications 63 OAB symptoms 63 neutrophil counts 63 PRADAXA #mg 63 TMC# r 63 ropivacaine 63 ARCALYST ® 63 lipid abnormalities 63 thromboembolic complications 63 discontinuations due 63 hypoglycaemic 63 cardiac toxicity 63 coronary stenosis 63 ADEs 63 revascularizations 63 CPAP adherence 63 depressive symptomatology 63 intima media thickness 63 hyperglycaemia 63 certolizumab 63 serologically active patients 63 improves glycemic 63 corticosteroid dose 63 MADRS score 63 systemic embolism 63 serum potassium levels 63 glycated hemoglobin HbA1c 63 rFVIIa 63 serum aminotransferase levels 63 nadolol 63 serum triglyceride levels 63 torsade de pointes 63 lispro alone 62 headache nasopharyngitis 62 psychiatric comorbidities 62 upper gastrointestinal bleeding 62 events MACE 62 concomitant medications 62 strong CYP#A# inducers 62 CrCl 62 anemia hemoglobin 62 REYATAZ r arm 62 renal insufficiency 62 postprocedure 62 coadministration 62 unresectable HCC 62 non hematological toxicities 62 constipation nausea 62 diastolic hypertension 62 aspartate aminotransferase 62 Serious adverse reactions 62 PREZISTA r 62 Primary endpoints 62 gout flare 62 A1c levels 62 hematological toxicity 62 adrenal suppression 62 biphasic insulin aspart 62 nonadherence 62 receiving VELCADE 62 elevated creatinine 62 hypocalcemia 62 MULTAQ 62 GERD symptom 62 VIIBRYD 62 myelosuppression 62 pruritus itching 62 T2DM 62 asthma exacerbations 62 paresthesias 62 binary restenosis 62 #mg/day [001] 62 decompensation 62 receiving VICTRELIS 62 urine albumin 62 neutropenia thrombocytopenia 62 NNT = 62 hypophosphatemia 62 virologic failure 62 dosing frequency 62 hyperbilirubinemia 62 colorectal adenoma 62 Exclusion criteria 62 annualized relapse 62 depressive symptom 62 symptomatic hyponatremia 62 fluid overload 62 atorvastatin #mg 62 aspartate aminotransferase AST 62 Peripheral edema 62 HBeAg seroconversion 62 abdominal adiposity 62 tapentadol IR 62 headache nausea fatigue 62 macrovascular 62 cardioembolic stroke 62 comorbidities 62 mcg BID 62 adjunctive placebo 62 events TEAEs 62 Hypocalcemia 62 platelet reactivity 62 induced hypoglycemia 62 fatal myocardial infarction 62 QT prolongation 62 RLAI 62 elevated IOP 62 symptomatic VTE 62 recurrent DVT 62 PREZISTA r arm 62 plasma creatinine 62 Severe hypoglycemia 62 coronary stenoses 62 pentoxifylline 62 rimonabant #mg 62 nocturnal awakenings 62 renal dysfunction 62 events AEs 62 intracerebral hemorrhage 62 hematologic toxicities 62 Adverse reactions 62 pulmonary capillary wedge 62 fasting glucose levels 62 exacerbations 62 balsalazide 62 Hb A1C 62 asthma exacerbation 62 myocardial infarctions 62 alanine aminotransferase 62 CCyR 62 serum PTH 62 hypercalcemia 62 EDSS scores 61 Suicidal ideation 61 VT VF 61 pathologic fractures 61 discontinuations 61 pulmonary dysfunction 61 glomerular filtration 61 perioperative complications 61 tolvaptan 61 GERD symptoms 61 Treatment emergent adverse 61 lactic acidosis 61 receiving ISENTRESS 61 #mg BID [003] 61 serum phosphorous 61 NNRTI resistance 61 hyperalgesia 61 ICD shocks 61 acromegalic patients 61 IIIa inhibitors 61 noncardiovascular mortality 61 spontaneous bowel movements 61 HF hospitalization 61 nonfatal myocardial infarction MI 61 tolterodine ER 61 chlorambucil 61 perioperative mortality 61 gastrointestinal bleeds 61 Renal impairment 61 salmeterol fluticasone 61 ECG abnormalities 61 NATRECOR R 61 albumin excretion rate 61 postoperative complications 61 ipsilateral stroke 61 moderate renal impairment 61 nadroparin 61 zolmitriptan 61 PRADAXA 61 endophthalmitis 61 tranylcypromine 61 induce orthostatic hypotension 61 pericardial effusion 61 paroxysmal AF 61 postoperative chemotherapy 61 angiographic restenosis 61 detemir 61 cerebrovascular accidents 61 cytogenetic response 61 alanine aminotransferase ALT 61 liver transaminases 61 ketoacidosis hyperosmolar coma 61 pulmonary exacerbations 61 ALT elevations 61 Crohn Disease Activity 61 subcutaneous insulin 61 overactive bladder symptoms 61 H2 receptor antagonists 61 recurrent atrial fibrillation 61 rebleeding 61 necrotizing pancreatitis 61 intraoperative complications 61 serum HCV RNA 61 hepatic enzymes 61 vertebral fracture 61 macrovascular disease 61 FluCAM arm 61 hypopneas 61 pancytopenia 61 HBeAg positive patients 61 intravenous diuretics 61 insulin degludec 61 lipid lowering medications 61 CIMZIA TM 61 adjunctive ABILIFY 61 neurologic sequelae 61 systolic BP 61 endometrial thickness 61 plasma triglycerides 61 p = NS 61 renal toxicity 61 undetectable viral 61 irbesartan 61 COPD exacerbations 61 metabolic parameters 61 FOLPI 61 hypokalemia 61 achieved statistical significance 61 advanced adenomas 61 OGTT 61 loop diuretics 61 solifenacin 61 angina chest 61 â ‰ ¥ 61 tumor lysis syndrome 61 elevated triglyceride levels 61 oral hypoglycemic agents 61 mesalamine granules 61 nonvertebral fractures 61 aminotransferase elevations greater 61 fasting triglycerides 61 mg kg dose 61 hemoptysis 61 fluoxetine paroxetine 61 mmHg diastolic 61 dosage regimens 61 systolic dysfunction 61 DLTs 61 SAEs 61 HBeAg negative patients 61 myocardial infarction stroke 61 events SAEs 61 decrements 61 leukopenia 61 achieving PASI 61 mycophenolate mofetil 61 ventricular fibrillation VF 61 carotid stenosis 61 serum creatinine levels 61 receiving XGEVA 61 4mg/kg 61 chronic GVHD 61 neuroleptics 61 affective psychoses 61 quetiapine 61 antiarrhythmic drug 61 ARCOXIA 61 cerebral vasospasm 61 clinically meaningful improvements 61 titrated glipizide 61 serum phosphorus 60 postintervention 60 gastrointestinal toxicity 60 baseline A1C 60 nausea photophobia 60 IRLS score 60 renal impairment 60 CANCIDAS 60 hepatic impairment 60 sustained ventricular tachycardia 60 metformin monotherapy 60 primidone 60 headache abdominal pain 60 venlafaxine Effexor 60 nevirapine Viramune 60 potassium sparing diuretics 60 gastrointestinal perforation 60 calculated creatinine clearance 60 acute gout flares 60 headache nausea diarrhea 60 extrapyramidal side 60 ribavirin therapy 60 gastrointestinal adverse reactions 60 tegaserod 60 serum calcium levels 60 inhaled fluticasone 60 hypomagnesemia 60 haematological toxicity 60 rhinoconjunctivitis 60 MMSE scores 60 silent ischemia 60 serum phosphate levels 60 flutamide 60 serum uric acid 60 orthostatic hypotension 60 HAM D# 60 antidiabetic medications 60 virologic response 60 maximal doses 60 virological response 60 ximelagatran 60 mean baseline HbA1c 60 plasma glucose 60 anaphylactoid reactions 60 rhinorrhea 60 severe hypoglycemic episodes 60 hyperammonemia 60 HAM D# scores 60 intermittent hypoxia 60 SRBD 60 antiemetics 60 clomipramine 60 mm Hg systolic 60 amenorrhea 60 tipranavir r 60 glycosylated hemoglobin 60 nonfatal stroke 60 oral antidiabetic medication 60 mcg kg REBETOL 60 timepoints 60 anemia neutropenia 60 serum leptin 60 serum phosphate 60 coagulopathy 60 GnRH agonists 60 treprostinil 60 neurodevelopmental impairment 60 hemodilution 60 postoperative delirium 60 LV dysfunction 60 artery occlusion 60 peri procedural 60 serum IGF 60 cardiovascular hospitalizations 60 biologic DMARD 60 ß blockers 60 somnolence sedation 60 hypomanic episodes 60 Events MACE 60 #.#/#.# mmHg [001] 60 elevated serum creatinine 60 pericardial effusions 60 Hepatotoxicity 60 lymphocytosis 60 coronary revascularization 60 DAS# CRP 60 fluticasone salmeterol 60 thromboprophylaxis 60 metabolic acidosis 60 ziprasidone 60 metformin sulphonylurea 60 lower extremity amputation 60 hallucinations dyskinesia 60 nasopharyngitis headache 60 SGOT 60 cerebral infarction 60 endometrial hyperplasia 60 CVD mortality 60 statin monotherapy 60 haloperidol Haldol 60 severe asthma exacerbations 60 anastomotic leak 60 lorazepam Ativan 60 aripiprazole 60 AGILECT R 60 neuropsychiatric symptoms 60 metformin accumulation 60 zonisamide SR 60 QTc interval 60 noncardiac 60 elevated LDL cholesterol 60 HbA 1C 60 variceal bleeding 60 QIDS SR 60 sedating antihistamine 60 parkinsonian symptoms 60 incidence ≥ 60 lymphopenia 60 ventricular tachyarrhythmia 60 neurologic dysfunction 60 Clinically significant 60 concomitant AEDs 60 protein excretion 60 rehospitalization 60 pulmonary toxicity 60 fluoxetine Prozac 60 hypertension diabetes mellitus 60 sulphonylureas 60 SGPT 60 salivary flow 60 dysuria 60 HbA1C 60 venlafaxine XR 60 glargine 60 oral antidiabetic agents 60 bezafibrate 60 #mmHg [001] 60 blood Phe levels 60 dyslipidaemia 60 mm Hg diastolic 60 serum triglycerides 60 antiepileptic drugs AEDs 60 desvenlafaxine succinate 60 deep venous thromboses 60 ischemic cardiovascular 60 splenectomized patients 60 TDF FTC 60 lenalidomide dexamethasone 60 Secondary endpoints 60 ventricular arrhythmia 60 del 5q MDS 60 proteinuria 59 mixed hyperlipidemia 59 hypotension 59 androgen excess 59 mg ustekinumab 59 inhaled budesonide 59 infarctions 59 primary hypercholesterolemia 59 Viread Emtriva Sustiva 59 triglyceride concentration 59 budesonide formoterol 59 pyrexia mucositis sepsis febrile 59 Thal Dex 59 ischemic complications 59 severe renal impairment 59 hypertensives 59 amenorrhoea 59 preintervention 59 Apidra ® 59 somatic symptoms 59 tamoxifen Nolvadex ® 59 macrovascular complications 59 oxycodone IR 59 CK # plasma concentrations 59 fosamprenavir 59 symptomatic hypotension 59 #mg/day [002] 59 femoral shaft fracture 59 nontraumatic 59 hepatic failure 59 thyrotropin levels 59 PSA nadir 59 fluvastatin 59 tolterodine 59 fasting triglyceride levels 59 proximal DVT 59 serum cortisol 59 ULORIC 59 quetiapine XR 59 diastolic BP 59 % CI #.#-#.# [004] 59 glulisine 59 genital ulcers 59 antihypertensive medication 59 QT intervals 59 mild renal insufficiency 59 glyburide 59 Tekamlo 59 LVSD 59 conjunctival hyperemia 59 tachyarrhythmias 59 left ventricular hypertrophy 59 hypersomnia 59 agitation hallucinations 59 bronchial hyperresponsiveness 59 neutropenic fever 59 omeprazole Prilosec 59 atrophic gastritis 59 atherothrombotic disease 59 decompensated heart failure 59 abdominal circumference 59 ABC/3TC 59 coronary revascularization procedures 59 Thrombotic events 59 overt nephropathy 59 glycemia 59 serum transaminases 59 extrapyramidal disorder 59 serum concentrations 59 DETROL LA 59 NIASPAN 59 Lantus ® 59 AST ALT 59 stent thromboses 59 % CI #.#-#.# [008] 59 transaminases 59 bisoprolol 59 achieved ACR# 59 p = .# [002] 59 placebo p 59 simvastatin ezetimibe 59 budesonide pMDI 59 plus methotrexate 59 dysmenorrhoea 59 peripheral edema 59 bloating abdominal pain 59 aneurysmal subarachnoid hemorrhage 59 Nesiritide 59 #mg doses [002] 59 diarrhea nausea fatigue 59 dalteparin 59 hyperglycemia 59 cerebrovascular accident 59 CYPHER ® 59 Lipitor #mg 59 symptom severity 59 elevated LDH 59 Fasting plasma glucose 59 systemic corticosteroids 59 prolactin levels 59 non valvular atrial 59 P = .# 59 intracranial bleeding 59 isolated systolic hypertension 59 cerebral ischemia 59 neutropenia dehydration dyspnea 59 prolactin elevation 59 gastric acidity 59 beta blocker therapy 59 cholecystitis 59 nephrotoxic 59 prospectively stratified 59 IELT 59 ZYVOX 59 SSRI SNRI 59 oxcarbazepine 59 nonmetastatic prostate cancer 59 PREZISTA rtv 59 atazanavir ritonavir 59 serum urate levels 59 divalproex sodium 59 risperidone Risperdal 59 pulmonary arterial 59 nonhematologic adverse reactions 59 myocardial infarction MI 59 Index CDAI 59 RAS blockers 59 venous thromboembolic disease 59 tirofiban 59 oral antidiabetes drugs 59 inhospital 59 antimuscarinic 59 elevated plasma concentrations 59 primary aldosteronism 59 Prehypertension 59 oral allopurinol 59 intravascular hemolysis 59 tipranavir ritonavir 59 preoperative PSA 59 plasma HCV RNA 59 adalimumab 59 musculoskeletal pain 59 Complication rates 59 dose colchicine 59 YMRS 59 QTc 59 valsartan amlodipine 59 lumiracoxib 59 thiazide 59 hepatic dysfunction 59 Adverse effects 59 eplerenone 59 procedural sedation 59 heparin induced thrombocytopenia 59 coinfected patients 59 hepatotoxicity 59 Thrombocytopenia 59 CK MB 59 angiographic outcomes 59 intensive statin therapy 59 antidiabetic drugs 59 triglyceride concentrations 59 IOP lowering 59 mucosal inflammation 59 Serious AEs 59 postprandial insulin 59 alfuzosin 59 rhythm disturbances 59 testicular tumors 59 nonischemic 59 thrombotic complications 59 predisposing factor 59 dysglycemia 59 oral corticosteroid 59 thioridazine 59 gemifloxacin 59 Recurrences 59 placebo dexamethasone 59 impaired cognition 59 thrombocytosis 59 A1C levels 59 clevidipine 59 refractory ischemia 59 rosuvastatin #mg 59 multivariable adjustment 59 undergoing CABG 59 piperacillin tazobactam 59 x ULN 59 enalapril 59 NYHA functional class 59 estimated GFR 59 nephrotoxic drugs 59 autonomic dysfunction 59 highly emetogenic 59 eosinophilia 59 hepatic enzyme 59 Avandia Actos 59 hypercapnia 59 NATRECOR ® 59 hypertensive patients 59 QTcF 59 benazepril 59 intraocular inflammation 59 revascularization procedures 59 preterm deliveries 59 p = #.# [003] 59 phonophobia 59 CYPHER Stent 59 daytime alertness 59 systemic hypotension 59 vasogenic edema 59 NIH CPSI 59 hyperreflexia 59 sinus tachycardia 59 venous hypertension 59 thyrotoxicosis 59 Abdominal pain 59 colorectal adenomas 59 glycated hemoglobin 59 renal flares 59 WARNINGS Myopathy Rhabdomyolysis 59 clinically meaningful improvement 59 nonfatal cardiovascular 59 UPDRS motor 59 comorbid psychiatric 59 comorbid depression 59 thromboses 59 unstable angina pectoris 59 cranial irradiation 59 steroid dexamethasone 59 multivariate adjustment 59 placebo p = 59 antidepressants fluoxetine 59 infarcts 59 corrected QT interval 59 elevated uric acid 59 limiting toxicity 59 carotid IMT 59 paricalcitol 59 rosuvastatin Crestor 59 FOSRENOL ® 58 antihypertensive drugs 58 endothelin receptor antagonists 58 virological failure 58 gastrointestinal toxicities 58 dapagliflozin plus 58 metabolic disturbances 58 electrolyte abnormalities 58 electrical cardioversion 58 serum homocysteine 58 hematologic abnormalities 58 posttreatment 58 Pioglitazone 58 MIRAPEX 58 paroxetine Paxil 58 #.#mg/dL 58 infusional 58 leukopenia pancytopenia thrombocytopenia 58 elevated transaminases 58 fractional shortening 58 neurologic symptoms 58 lymphocyte count 58 INFERGEN 58 endoscopic remission 58 symptomatic hypoglycemia 58 Baseline characteristics 58 narcotic analgesics 58 antihypertensive agents 58 Score DAS# 58 hepatorenal syndrome 58 XIENCE V PROMUS Stent 58 estimated glomerular filtration 58 posaconazole 58 CP CPPS 58 thiazide diuretic 58 symptomatic intracranial hemorrhage 58 hypovolemia 58 INVEGA ® 58 pulmonary exacerbation 58 levodopa therapy 58 hip BMD 58 lacosamide 58 urate lowering 58 infusion reactions 58 bronchopulmonary dysplasia 58 mucocutaneous reactions 58 dermatologic reactions 58 comparator arm 58 asymptomatic PAD 58 pretreatment baseline 58 ACTOplus met XR 58 bladder contractions 58 locomotor activity 58 Exacerbations 58 Paxil paroxetine 58 seropositive patients 58 mmol l 58 cerebral oxygenation 58 blood oxygen saturation 58 anemia thrombocytopenia 58 sulfasalazine 58 epistaxis 58 antihypertensive therapy 58 serum HBV DNA 58 ischemic cardiomyopathy 58 reoperations 58 systemic corticosteroid 58 FOLFOX4 58 symptom flare ups 58 urinary leakage 58 serum parathyroid hormone 58 atrial arrhythmias 58 infarct size 58 pooled comparator 58 androgen deprivation 58 polyp recurrence 58 tamsulosin 58 IBDQ 58 thiazide diuretics 58 creatinine clearance 58 ventricular repolarization 58 RAPTIVA 58 composite endpoint 58 IDDM 58 BENICAR HCT 58 angiotensin II receptor blockers 58 Myelosuppression 58 dyspareunia 58 somnolence sleepiness 58 mania hypomania 58 asymptomatic carotid stenosis 58 autoantibody levels 58 contrast induced nephropathy 58 LANTUS R 58 T2 lesions 58 delayed CINV 58 CLA supplementation 58 Secondary endpoints include 58 cardiac dysfunction 58 renal artery stenosis 58 GI bleeds 58 lipid lowering medication 58 antiandrogen 58 ritonavir boosted 58 hepatic function 58 sumatriptan naproxen sodium 58 Fasting blood glucose 58 reintubation 58 tardive dyskinesia TD 58 LOVENOX R 58 CI #.#-#.# [001] 58 hematological toxicities 58 Elitek 58 Serious Adverse Events 58 noncardiovascular 58 generalized seizures 58 nausea constipation 58 lopinavir r 58 fasting plasma glucose FPG 58 alanine transaminase 58 atrioventricular block 58 comorbid disorders 58 Fluid retention 58 postsurgical complications 58 HBeAg 58 Anaphylactic reactions 58 MCyR 58 non selective NSAIDs 58 retinal vein occlusion 58 androgen depletion 58 apneas 58 graft occlusion 58 depressive symptoms 58 ejection fractions 58 PEGINTRON TM 58 MetS 58 lamotrigine 58 conventional antipsychotics 58 dermatologic toxicities 58 oral levofloxacin 58 serum sodium levels 58 thrombocytopenic 58 homozygous familial hypercholesterolemia 58 venous thrombosis 58 postoperative bleeding 58 μg dose 58 anemia leukopenia 58 cerebral oxygen saturation 58 vitreous floaters 58 lumbar spine BMD 58 untreated OSA 58 mL kg 58 hemorrhagic cystitis 58 mg simvastatin 58 inflammatory lesions 58 rizatriptan 58 obstructive CAD 58 clodronate 58 extubation 58 VaD 58 nonsignificant 58 eosinophil count 58 terazosin 58 leukocyte count 58 Tardive dyskinesia 58 transaminase levels 58 PREZISTA ritonavir 58 elevated lipase 58 myalgia arthralgia 58 failure ADHF 58 postprandial glucose 58 tertile 58 antiepileptics 58 Scale EDSS score 58 Atypical antipsychotics 58 airflow limitation 58 treat NNT 58 POAG 58 delayed gastric emptying 58 AEs 58 chronic LBP 58 detrusor overactivity